US Patent Issued to Boehringer Ingelheim International on Nov. 25 for "Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors" (German, Swiss Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,827, issued on Nov. 25, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors" was invented by Matthias Eckhardt (Biberach an der Riss, Germany), Maude Giroud (Basel, Switzerland), Elke Langkopf (Biberach an der Riss, Germany), Camilla Mayer (Warthausen, Germany), Holger Wagner (Mettenberg, Germany) and Dieter Wiedenmayer (Bieberach an der Riss, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are heteroaromatic carboxamides of formula (I),wherein Y, R, and Ar are as defined herein, and pharmaceutically acceptable salts thereof. A...